Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production

New positive data for Janssen's esketamine depression treatment, MSD buys Peloton Therapeutics for $2.1 billion, and Gilead CEO grilled on why its...
New research has been published on the efficacy of esketamine in the treatment of depression, following its approval from the FDA in the US in...
GP consultations should be five minutes longer, with 10 minute doctors’ appointments being a ‘thing of the past,’ according to a report from the...
Researchers at Imperial College London (ICL) and Johannes Gutenberg University Mainz have shown that xenon prevents early death and long-term...

Features

Dr Bill Love, Founder and Chief Scientific Officer of Destiny Pharma, discusses the rise of antimicrobial resistance (AMR), the antibiotic...

Appointments

Rare disease and oncology biopharma firm EUSA Pharma has revealed two new additions to its senior leadership team in two newly-created roles: Dr...

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches